Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

GE Healthcare Japan enters collaboration with Nihon Medi-Physics for Abeta-imaging product

April 10, 2014

Ventana Medical Systems signs companion diagnostic agreement with Genmab

April 9, 2014

Qbtech launches FDA-cleared ADHD test

April 4, 2014

Cepheid confirms launch of Xpert HPV, a rapid test for cervical cancer-related HPV

April 4, 2014

MDxHealth and LI PATH enter into marketing agreement for ConfirmMDx

April 4, 2014

Allegro Diagnostics reports results from BronchoGen genomic test trial

April 4, 2014

Venaxis seeks FDA clearance of APPY1 Test for appendicitis

April 3, 2014

OPKO Health launches 4Kscore test for prostate cancer

April 2, 2014

FDA committee recommends approval of Cologuard colorectal cancer screening test

April 1, 2014

Meridian Biosciences' illumigene Pertussis test cleared by the FDA

April 1, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.